How Does HTLV-1 Persist in the Host?
Viruses · 2026
DOI: 10.3390/v18101121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Charles R M Bangham. Beteiligte Einrichtung: Department of Infectious Disease, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, HTLV-I Infections, Host-Pathogen Interactions, Persistent Infection. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
HTLV-1 resists clearance from its host by the strong HTLV-1-specific immune response and by drugs. The tactics and strategies by which it does so illustrate the exquisite adaptation to the host that HTLV-1 has made in its tens of thousands of years of stable co-existence with humans. This adaptation contrasts strongly with the biology of HIV-1, which has established widespread infection in humans for only around a century. The mode of persistence of HTLV-1 makes it less pathogenic than HIV-1, despite causing serious malignant and inflammatory diseases in a proportion of people with the virus, but at the same time makes HTLV-1 harder to treat and eradicate. In this article I outline the different means that HTLV-1 has evolved to persist in the host.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Disease, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
ORCID-Profile: Charles R M Bangham
Zitieren
APA
Bangham, C. R. M. (2026). How Does HTLV-1 Persist in the Host?. Viruses. https://doi.org/10.3390/v18101121
Vancouver
Bangham CRM. How Does HTLV-1 Persist in the Host?. Viruses. 2026. doi:10.3390/v18101121
BibTeX
@article{Bangham2026,
author = {Bangham, Charles R M},
title = {How Does HTLV-1 Persist in the Host?},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18101121}
}
EUVIMED